For individuals 60 and older, RSV vaccination is advised by FDA specialists. Future plans

The second of two new vaccines intended for persons 60 and older to avoid serious illness was declared safe and effective for older adults on Wednesday by a Food and Drug Administration advisory panel. The RSV vaccine is still being reviewed by the agency. The FDA commissioner must still provide his or her final approval before the Pfizer and GSK vaccines can be released, and an advisory group at the Centers for Disease Control and Prevention ....